価格表

在庫・価格 : 2024年06月16日 02時04分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-IgG2c, Mouse, Goat-Poly, HRP
データシート
A90-136P BETベチル ラボラトリーズ
Bethyl Laboratories, Inc.
1 mg ¥47,000
(未発注)
追加

在庫・価格 : 2024年06月16日 02時04分 現在

Anti-IgG2c, Mouse, Goat-Poly, HRP

  • 商品コード:A90-136P
  • メーカー:BET
  • 包装:1mg
  • 価格: ¥47,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Zimring JC et al. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 2005 Aug;106(3):1105-12
Zimring JC et al
2005/01/01
PubMed
2 Matsumoto S et al. DNA augments antigenicity of mycobacterial DNA-binding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice. J. Immunol. 2005 Jul;175(1):441-9
Matsumoto S et al
2005/01/01
PubMed
3 Ehlers M et al. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 2006 Mar;203(3):553-61
Ehlers M et al
2006/01/01
PubMed
4 Kaneko Y et al. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J. Exp. Med. 2006 Mar;203(3):789-97
Kaneko Y et al
2006/01/01
PubMed
5 Inoue Y et al. Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice. J. Immunol. 2007 Jul;179(2):764-74
Inoue Y et al
2007/01/01
PubMed
6 Oefner CM et al. Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J. Allergy Clin. Immunol. 2012 Jun;129(6):1647-55.e13
Oefner CM et al
2012/01/01
PubMed
7 Yu L et al. Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice. Parasitol. Int. 2012 Sep;61(3):481-6
Yu L et al
2012/01/01
PubMed
8 Almer G et al. Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes. Mol. Pharm. 2013 Jan;10(1):175-86
Almer G et al
2013/01/01
Applications: ELISA PubMed
9 Hess C et al. T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J. Clin. Invest. 2013 Sep;123(9):3788-96
Hess C et al
2013/01/01
PubMed
10 Ilyinskii PO et al. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine 2014 Mar;
Ilyinskii PO et al
2014/01/01
PubMed
  • No.: 1
  • 文献情報:
    Zimring JC et al. Nonhemolytic antibody-induced loss of erythrocyte surface antigen. Blood 2005 Aug;106(3):1105-12
    Zimring JC et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Matsumoto S et al. DNA augments antigenicity of mycobacterial DNA-binding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice. J. Immunol. 2005 Jul;175(1):441-9
    Matsumoto S et al
    2005/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Ehlers M et al. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J. Exp. Med. 2006 Mar;203(3):553-61
    Ehlers M et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Kaneko Y et al. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors. J. Exp. Med. 2006 Mar;203(3):789-97
    Kaneko Y et al
    2006/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Inoue Y et al. Activating Fc gamma receptors participate in the development of autoimmune diabetes in NOD mice. J. Immunol. 2007 Jul;179(2):764-74
    Inoue Y et al
    2007/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Oefner CM et al. Tolerance induction with T cell-dependent protein antigens induces regulatory sialylated IgGs. J. Allergy Clin. Immunol. 2012 Jun;129(6):1647-55.e13
    Oefner CM et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Yu L et al. Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice. Parasitol. Int. 2012 Sep;61(3):481-6
    Yu L et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Almer G et al. Interleukin-10: an anti-inflammatory marker to target atherosclerotic lesions via PEGylated liposomes. Mol. Pharm. 2013 Jan;10(1):175-86
    Almer G et al
    2013/01/01
  • 備考:
    Applications: ELISA
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Hess C et al. T cell-independent B cell activation induces immunosuppressive sialylated IgG antibodies. J. Clin. Invest. 2013 Sep;123(9):3788-96
    Hess C et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Ilyinskii PO et al. Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release. Vaccine 2014 Mar;
    Ilyinskii PO et al
    2014/01/01
  • 備考:
  • 参照:
    PubMed